Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v8-FR
Language French French
Date Updated 2023-02-10 2023-02-10
Drug Identification Number 02267993 02267993
Brand name TARO-ATENOLOL TARO-ATENOLOL
Common or Proper name ATENOLOL ATENOLOL
Company Name SUN PHARMA CANADA INC SUN PHARMA CANADA INC
Ingredients ATENOLOL ATENOLOL
Strength(s) 100MG 100MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code C07AB C07AB
ATC description BETA BLOCKING AGENTS BETA BLOCKING AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-12-21 2022-12-21
Estimated end date 2023-02-03 2023-02-03
Actual end date 2023-02-03 2023-02-03
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments